Announcement of Shandong Buchang Pharmaceutical Co., Ltd. on the completion of medical device business license change registration for its holding subsidiary
Announcement of Shandong Buchang Pharmaceutical Co., Ltd. on the wholly-owned subsidiary obtaining a drug registration certificate
Announcement of Shandong Buchang Pharmaceutical Co., Ltd. on the wholly-owned subsidiary obtaining a drug registration certificate
Announcement of Shandong Buchang Pharmaceutical Co., Ltd. on the receipt of GMP compliance test results by its wholly-owned subsidiary
Announcement of Shandong Buchang Pharmaceutical Co., Ltd. on the holding subsidiary obtaining a notice of acceptance of drug registration
Announcement of Shandong Buchang Pharmaceutical Co., Ltd. on the receipt of GMP compliance test results by its wholly-owned subsidiary
Announcement of Shandong Buchang Pharmaceutical Co., Ltd. on the completion of industrial and commercial change registration for its wholly-owned subsidiary
Announcement of Shandong Buchang Pharmaceutical Co., Ltd. on changes in the pharmaceutical production license of its wholly-owned subsidiary
Announcement of Shandong Buchang Pharmaceutical Co., Ltd. on the reduction of registered capital and related transactions of the holding subsidiary
Announcement of Shandong Buchang Pharmaceutical Co., Ltd. on changes in the business scope of its subsidiary
Announcement from Shandong Buchang Pharmaceuticals Co., Ltd. regarding the pharmaceutical production permit change of its wholly-owned subsidiary.
Announcement of Shandong Buchang Pharmaceuticals Co., Ltd. regarding its controlling subsidiary, Lanzhou Buchang, signing the Distributing and Licensing Agreement on Injection BC001 with LANCET.
Announcement of Shandong Buchang Pharmaceuticals Co., Ltd.'s wholly-owned subsidiary obtaining pharmaceutical registration certificate.
Announcement on the Proposed Establishment of a Holding Subsidiary by Shandong Buchang Pharmaceuticals Co., Ltd. for External Investment.
Shandong Buchang Pharmaceuticals Co., Ltd.'s 2024 "Quality Improvement and Efficiency Enhancement Return" action plan.
Announcement from Shandong Buchang Pharmaceuticals Co., Ltd. regarding the signing of a technology service (commission) contract by its subsidiary.
Announcement of Shandong Buchang Pharmaceuticals Co., Ltd. on the completion of industrial and commercial registration changes of its holding subsidiary.
Announcement from Shandong Buchang Pharmaceuticals Co., Ltd. regarding the "Quality Improvement, Efficiency Enhancement, and Return" action plan for the year 2024.
Announcement on Shandong Buchang Pharmaceuticals Co., Ltd.'s subsidiary completing the registration of change of operation permit of medical instruments.
Announcement of Shandong Buchang Pharmaceuticals Co., Ltd. regarding its holding subsidiary obtaining a notice of approval for drug clinical trials.
No Data